SOMATOSTATIN PHYSIOLOGY IN DIABETES AND OBESITY
SOMATOSTATIN PHYSIOLOGY IN DIABETES AND OBESITY
批准号:
3154585
负责人:
MICHAEL BERELOWITZ
金额:
$11.19万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-07-01 至 1987-07-30
关键词:
aminoacid central nervous system disease /disorder model experimental brain lesion fatty acids gastrointestinal hormones glucagon glucose glucose metabolism high performance liquid chromatography homeostasis hormone biosynthesis hormone regulation /control mechanism hypothalamic pituitary axis insulin ketone body molecular pathology nerve endings neurohormones neurons nutrition related tag obesity pancreas hormone radioimmunoassay radiotracer secretion somatostatin
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Somatostatin (SRIF)-like immunoreactivity (SRIF-LI) is widely distributed
through the central nervous system as well as being present in D-cells of
the pancreatic islets and gut. SRIF and other peptides with a similar
widespread tissue distribution have been identified in unicellular
organisms and may be ancient in evolutionay terms. Primeval functions of
such peptides may have changed according to local tissue needs with
increasing complexity of the organism, as may the mode of delivery
(neurotransmission, endocrine or paracrine), while their original overall
role may have been retained. In the pancreas and gut SRIF-LI responds to
ingested food and circulating nutrients and appears to play a role in the
regulation of nutrient homeostasis by influencing both nutrient entry and
disposition. The hypothalamus influences nutrient homeostasis through
modulation of pituitary hormone secretion, appetite regulation and
autonomic nervous control over peripheral glucoregulation. SRIF-LI is
present in hypothalamic neurones in areas important in these activities and
SRIF influences all three aspects of hypothalamic function. This proposal
is based on the hypothesis that SRIF in the hypothalamus, like that in the
pancreas and gut, reponds to nutrient stimuli to mediate hypothalamic
influences on metabolic control In accordance with this hypothesis
hypothalamic lesions that affect metabolic control would alter nutrient
regulation of hypothalamic SRIF. Conversely, abnormal peripheral nutrient
regulation of hypothalamic SRIF. Conversely, abnormal peripheral nutrient
homeostasis woul influence hypothalamic function through disturbances of
SRIF regulation. Studies in this proposal are designed to examine this
hypothesis by identifying nutrient influences on hypothalamic SRIF-LI
secretion and then evaluating disturbances of hypothalamic SRIF-LI
regulation (biosynthesis, nuclear content, secretion and molecular
heterogeneity) resulting from hypothalamic nuclear lesions or diabetes
mellitus.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Glucopenia-mediated release of somatostatin from incubated rat hypothalamus: monosaccharide specificity and role of glycolytic intermediates.
葡萄糖减少症介导的孵化大鼠下丘脑生长抑素的释放:单糖特异性和糖酵解中间体的作用。
DOI:
10.1210/endo-124-2-826
发表时间:
1989
期刊:
Endocrinology
影响因子:
4.8
作者:
[Berelowitz,M, Ting,NC, Murray,L]
通讯作者:
Murray,L
Pituitary insulin-like growth factor-I content and gene expression in the streptozotocin-diabetic rat: evidence for tissue-specific regulation.
链脲佐菌素糖尿病大鼠的垂体胰岛素样生长因子 I 含量和基因表达:组织特异性调节的证据。
DOI:
10.1210/endo-128-2-923
发表时间:
1991
期刊:
Endocrinology
影响因子:
4.8
作者:
[Olchovsky,D, Bruno,JF, Gelato,MC, Song,J, Berelowitz,M]
通讯作者:
Berelowitz,M
GLIPIZIDE-GITS AND METFORMIN ALONE VS COMBINATION THERAPY IN NIDDM
-
批准号:6283019
-
项目类别:
-
资助金额:$2.44万
-
财政年份:1998
-
负责人:MICHAEL BERELOWITZ
-
依托单位:
GLIPIZIDE-GITS AND METFORMIN ALONE VS COMBINATION THERAPY IN NIDDM
-
批准号:6123137
-
项目类别:
-
资助金额:$5.08万
-
财政年份:--
-
负责人:MICHAEL BERELOWITZ
-
依托单位:
海外基金